Ten‐year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4‐weekly or 8‐weekly
F. Vincenti; G. Blancho; A. Durrbach; G. Grannas; J. Grinyó; H.‐U. Meier‐Kriesche; M. Polinsky; L. Yang; C. P. Larsen
Author Information: University of California, San Francisco
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.